Dogwood Therapeutics, Inc. (NASDAQ:DWTX)
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$36.0M
- Net margin
- —
Little or no net debt.
- Total debt
- $127K
- Cash
- $9.6M
- Debt / equity
- 0.00
Comfortably covers what is due within a year.
- Current assets
- $11.0M
- Current liabilities
- $2.8M
- Current ratio
- 3.89
Consumes cash and must keep raising it.
- Operating cash flow
- -$15.1M
- Free cash flow
- -$15.1M
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 34.1M
- Share growth (1y)
- 2267.6%
- Cash runway
- 8 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
DWTX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 16.69 K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | -16.69 K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 1.61 M | 2.41 M | 1.47 M | 1.29 M | 1.35 M | 1.99 M |
| R&D Expense | 3.25 M | 2.67 M | 2.34 M | 14.52 M | 2.57 M | 2.44 M |
| Operating Expenses | 4.86 M | 5.08 M | 3.81 M | 15.81 M | 3.92 M | 4.43 M |
| Operating Income | -4.87 M | -5.08 M | -3.81 M | -15.81 M | -3.92 M | -4.43 M |
| Pretax Income | -14.01 M | -4.99 M | -3.75 M | -15.75 M | -3.81 M | -10.73 M |
| Tax Provision | -2.48 M | -1.19 K | 31.84 K | -1.44 K | 149.00 | 190.54 K |
| Net Income | -11.53 M | -4.99 M | -3.78 M | -15.74 M | -3.81 M | -10.92 M |
| EPS (Basic) | -0.34 | -0.15 | -0.26 | -8.20 | -1.99 | -8.45 |
| EPS (Diluted) | -0.34 | -0.15 | -0.26 | -8.20 | -1.99 | -8.45 |
| Shares Outstanding | 34.13 M | 33.54 M | 14.52 M | 1.92 M | 1.44 M | 1.44 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.